Approvals/TGA/ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack

Approved

STANDARD

ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: 8bf5deeaceaa0477
Product Name: ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack
Artg Id: 281025
Artg Name: ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2017-10-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

8bf5deeaceaa0477

Type

Standard